Title Page
1.0 Introduction
2.0 Literature Review
3.0 Model Framework
4.0 Scenarios
4.1 Life Stages
4.2 Scenario 1
Model Flow Diagram 1
4.3 Scenario 2
Model Flow Diagram 2
4.4 Scenario 3
Model Flow Diagram 3
4.5 Scenario 4
Model Flow Diagram 4
4.6 Process Flow
4.7 Gap Analysis
5.0 Qualitative Analysis
6.0Recommendations
7.0 References
Appendix A
|
The following Scenario 2 Process Flow Diagram illustrates
the mapping between the models and the process numbers.
Select a model or model description from the table below (ordered alphabetically),
and the corresponding processes on the diagram will be highlighted.
Figure 4.6.7 Scenario 2 Process Framework: Exposure of Compound C (DEHP or BBP or DINP) to newborn (or nursing infant) directly and via mother through milk
Notes
- Compound C: DEHP: diethyl hexyl phthalate
- Metabolite: Not Known
- Mode of Action: Not Known
- Data gap: No models for #5 partitioning between vapor and particle phase or #10 particle resuspension from surfaces (especially floors)
- Data gap: newborn and nursing infant PBPK or PBPD for DEHP
- Compound C: BBP: butyl benzyl phthalate
- Metabolite: Not found during literature search
- Mode of Action: Not found during literature search
- Data gap: No models for #5 partitioning between vapor and particle phase or #10 particle resuspension from surfaces (especially floors)
- Data gap: nursing infant PBPK for BBP
- Compound C: DINP: diisononyl phthalate
- Metabolite: Not Known
- Mode of Action: Not Known
- Data gap: No models for #5 partitioning between vapor and particle phase or #10 particle resuspension from surfaces (especially floors)
- Data gap: newborn and nursing infant PBPK for DINP
Return to Process Framework list.
|